Category:FDA approved in 2016

From HemOnc.org - A Hematology Oncology Wiki

Jump to: navigation, search

Medications in this category received their initial FDA approval in 2016.

Pages in category "FDA approved in 2016"

The following 6 pages are in this category, out of 6 total.

A

Atezolizumab (Tecentriq)

D

Defibrotide (Defitelio)

G

Granisetron (Sustol)

O

Olaratumab (Lartruvo)

R

Rucaparib (Rubraca)

V

Venetoclax (Venclexta)

Retrieved from "https://hemonc.org/w/index.php?title=Category:FDA_approved_in_2016&oldid=41540"

FDA approved in the 2010s